Phenylalanine is an important amino acid, which is one of the key components of proteins. It is a non-polar amino acid with a side chain containing phenyl and propylamino acids and has a molecular formula of C9H11NO2 and a molecular weight of 165.19 g/mol. Phenylalanine is essential for the human body and cannot be synthesized on its own; it must be obtained from food. Phenylalanine can be converted to tyrosine and tryptophan in the body, and these compounds play a key role in neurotransmitter synthesis and in vivo metabolism. In addition, it is involved in glycogen and fatty acid metabolism and participates in a variety of metabolic pathways. Phenylalanine has a wide range of applications in biomedical, food and cosmetic fields.
What is the relationship between phenylalanine and disease?
When it comes to phenylalanine, I believe that many people may not be familiar with it, but when it comes to phenylketonuria, I believe that many people are not unfamiliar with it, and even talk about "phenylketonuria". So, how are phenylalanine and phenylketonuria linked together? Let's analyze it.
Hyperphenylalaninemia (HPA) is a group of the most common abnormalities of amino acid metabolism, caused by a deficiency of phenylalanine hydroxylase (PAH) or its coenzyme tetrahydrobiopterin (BH4), resulting in an increase in blood Phenylalanine hydroxylase (PAH) or its coenzyme tetrahydrobiopterin (BH4) deficiency causes elevated blood phenylalanine concentrations, leading to brain damage, about 90% of which is due to PAH deficiency. Phenylketonuria (PKU) is a common amino acid metabolic disorder caused by an enzyme defect in the phenylalanine (PA) metabolic pathway that prevents the conversion of phenylalanine to tyrosine, resulting in the accumulation of phenylalanine and its ketoacids, which are excreted in large quantities in the urine. The disease is relatively common among inherited amino acid metabolism deficiency disorders and is inherited in an autosomal recessive manner. The clinical manifestations are heterogeneous and the main clinical features are mental retardation, psychoneurological symptoms, eczema, skin scratching signs and pigmentation loss and mouse odor, and EEG abnormalities. If early diagnosis and treatment are obtained, the aforementioned clinical manifestations may not occur, intelligence may be normalized, and EEG abnormalities may be restored.

